Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000541061 | SCV000852150 | benign | Phenylketonuria | 2018-08-10 | reviewed by expert panel | curation | PAH-specific ACMG/AMP criteria applied: BS1: MAF=0.01361 in ENF from gnomAD; BS2: 19 homozygotes in gnomAD. In summary this variant meets criteria to be classified as benign for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (BS1, BS2). |
Eurofins Ntd Llc |
RCV000174235 | SCV000225502 | benign | not specified | 2015-02-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000174235 | SCV000303441 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000088814 | SCV000515909 | benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 9781015) |
Labcorp Genetics |
RCV000541061 | SCV000629183 | benign | Phenylketonuria | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000088814 | SCV000889564 | benign | not provided | 2018-04-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000174235 | SCV000917926 | benign | not specified | 2018-05-29 | criteria provided, single submitter | clinical testing | Variant summary: PAH c.1242C>T alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0074 in 277168 control chromosomes, predominantly within the Non-Finnish European subpopulation at a frequency of 0.014 (in the gnomAD database), including 16 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.77 fold of the estimated maximal expected allele frequency for a pathogenic variant in PAH causing Hyperphenylalaninemia phenotype (0.0079), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. To our knowledge, no experimental evidence demonstrating its impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Illumina Laboratory Services, |
RCV000541061 | SCV001268942 | benign | Phenylketonuria | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Ce |
RCV000088814 | SCV004131787 | benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | PAH: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV000088814 | SCV005235485 | benign | not provided | criteria provided, single submitter | not provided | ||
De |
RCV000088814 | SCV000119405 | not provided | not provided | no assertion provided | not provided | ||
Genome Diagnostics Laboratory, |
RCV000174235 | SCV002034185 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000174235 | SCV002034918 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000541061 | SCV002088619 | benign | Phenylketonuria | 2019-12-09 | no assertion criteria provided | clinical testing |